Keio spinout Heartseed has added $37m to its coffers thanks to the university's Innovation Initiative and UTokyo Innovation Platform.
Heartseed, a Japan-based myocardial regenerative medicine developer spun out of Keio University’s School of Medicine, has picked up $37m in a series C round backed by Keio’s Innovation Initiative and University of Tokyo’s Innovation Platform.
The round also included financial services firm Sumitomo Mitsui Trust Bank’s Sumitomo Mitsui Trust Investment unit and investment firm Medical Incubator Japan, financial services firm SBI Group, and banking group Sumitomo Mitsui Banking Corporation’s SMBC Venture Capital vehicle.
Insurer Nippon Life’s Nissay Capital…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
